$41.09
0[0.00%]
Last update: 4:00PM Get Real Time Here
Xenon Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Xenon Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | PM | XENE | Q1 | -$0.63 | -$0.66 | — | — | $0.00 | — | — | — | Get Alert |
02/29/2024 | PM | XENE | Q4 | -$0.57 | -$0.76 | -$0.64 | 15.79% | $0.00 | $1.89M | $0.00 | -100.00% | Get Alert |
11/08/2023 | PM | XENE | Q3 | -$0.57 | -$0.77 | -$0.73 | 5.19% | $132.00K | $1.45M | $0.00 | -100.00% | Get Alert |
08/09/2023 | PM | XENE | Q2 | -$0.55 | -$0.70 | -$0.72 | -2.86% | $536.00K | $400.00K | $0.00 | -100.00% | Get Alert |
05/09/2023 | PM | XENE | Q1 | -$0.35 | -$0.62 | -$0.63 | -1.61% | $8.77M | $570.00K | $0.00 | -100.00% | Get Alert |
03/01/2023 | PM | XENE | Q4 | -$0.48 | -$0.58 | -$0.57 | 1.72% | $3.74M | $2.28M | $0.00 | -100.00% | Get Alert |
11/08/2022 | PM | XENE | Q3 | -$0.36 | -$0.52 | -$0.57 | -9.62% | $8.12M | $3.02M | $132.00K | -95.63% | Get Alert |
08/09/2022 | PM | XENE | Q2 | -$0.51 | -$0.48 | -$0.55 | -14.58% | $2.22M | $3.55M | $536.00K | -84.90% | Get Alert |
05/10/2022 | PM | XENE | Q1 | -$0.42 | -$0.41 | -$0.35 | 14.63% | $4.36M | $8.70M | $8.77M | 0.76% | Get Alert |
03/01/2022 | PM | XENE | Q4 | -$0.34 | -$0.37 | -$0.48 | -29.73% | $5.15M | $4.97M | $3.74M | -24.81% | Get Alert |
11/10/2021 | PM | XENE | Q3 | -$0.25 | -$0.38 | -$0.36 | 5.26% | $6.55M | $10.22M | $8.12M | -20.51% | Get Alert |
08/11/2021 | PM | XENE | Q2 | $0.00 | -$0.48 | -$0.51 | -6.25% | $13.38M | $2.33M | $2.22M | -4.81% | Get Alert |
05/11/2021 | PM | XENE | Q1 | -$0.22 | -$0.40 | -$0.42 | -5.00% | $7.08M | $5.15M | $4.36M | -15.38% | Get Alert |
03/01/2021 | PM | XENE | Q4 | -$0.41 | -$0.40 | -$0.34 | 15.00% | $3.33M | $3.22M | $5.15M | 59.94% | Get Alert |
11/05/2020 | PM | XENE | Q3 | -$0.33 | -$0.15 | -$0.25 | -66.67% | $3.50M | $10.06M | $6.55M | -34.85% | Get Alert |
08/06/2020 | PM | XENE | Q2 | -$0.37 | -$0.24 | $0.00 | 100.00% | $0.00 | $6.90M | $13.38M | 93.97% | Get Alert |
05/21/2020 | PM | XENE | Q1 | -$0.42 | -$0.32 | -$0.22 | 31.25% | $0.00 | $4.50M | $7.08M | 57.29% | Get Alert |
03/09/2020 | PM | XENE | Q4 | -$0.29 | -$0.49 | -$0.41 | 16.33% | $0.00 | $5.00M | $3.33M | -33.42% | Get Alert |
11/05/2019 | PM | XENE | Q3 | -$0.63 | -$0.48 | -$0.33 | 31.25% | $0.00 | — | $3.50M | — | Get Alert |
Xenon Pharmaceuticals (XENE) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
The Actual EPS was $-0.64, which beat the estimate of $-0.76.
The Actual Revenue was $0K, which missed the estimate of $1.9M.
Browse earnings estimates, EPS, and revenue on all stocks.